These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32710873)

  • 41. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 42. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.
    Khan MY; Kinsara AJ; Osoba AO; Wali S; Samman Y; Memish Z
    Int J Antimicrob Agents; 2001 May; 17(5):415-8. PubMed ID: 11337231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An international legal framework to address antimicrobial resistance.
    Hoffman SJ; Outterson K; Røttingen JA; Cars O; Clift C; Rizvi Z; Rotberg F; Tomson G; Zorzet A
    Bull World Health Organ; 2015 Feb; 93(2):66. PubMed ID: 25883395
    [No Abstract]   [Full Text] [Related]  

  • 44. Tuberculosis makes it onto the international political agenda for health…finally.
    Raviglione M; Uplekar M; Weil D; Kasaeva T
    Lancet Glob Health; 2018 Jan; 6(1):e20-e21. PubMed ID: 29153722
    [No Abstract]   [Full Text] [Related]  

  • 45. [Surveillance of resistance to antitubercular drugs in Cuba, 2000-2009].
    Montoro E; Lemus D; Echemendia M; Diaz R; Mederos L; Martinez MR; Llop A; Llanes MJ
    Rev Panam Salud Publica; 2011 Dec; 30(6):615-8. PubMed ID: 22358412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mycobacterium tuberculosis and atypical mycobacterioses].
    Bartsch P
    Rev Med Liege; 1999 Aug; 54(8):691-7. PubMed ID: 10548898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing the impact of defining a global priority research agenda to address HIV-associated tuberculosis.
    Odone A; Matteelli A; Chiesa V; Cella P; Ferrari A; Pezzetti F; Signorelli C; Getahun H
    Trop Med Int Health; 2016 Nov; 21(11):1420-1427. PubMed ID: 27576587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tuberculosis: the continuing story.
    Tynes LL
    JAMA; 1993 Dec; 270(21):2616-7. PubMed ID: 8230651
    [No Abstract]   [Full Text] [Related]  

  • 49. Immigration and a sneak resurgence of tuberculosis: déjà vu.
    Aliyu ZY
    Wien Klin Wochenschr; 2003 Sep; 115(17-18):611-4. PubMed ID: 14603731
    [No Abstract]   [Full Text] [Related]  

  • 50. Antituberculosis drug-resistance surveillance as a tool for tuberculosis control programmes: a retrospective study.
    La Raja M; Screm C; Talmassons G; Pasquadibisceglie A; Pitzalis G; Pitzus E
    Monaldi Arch Chest Dis; 1997 Oct; 52(5):450-4. PubMed ID: 9510665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tuberculosis in Russia.
    Oswald GR; Afanasicv NY; Cegielski JP; Binkin NJ
    Lancet; 1999 Sep; 354(9183):1036. PubMed ID: 10501397
    [No Abstract]   [Full Text] [Related]  

  • 53. European recommendations on surveillance of antituberculosis drug resistance.
    Wkly Epidemiol Rec; 2001 Jan; 76(1):2-5. PubMed ID: 11206027
    [No Abstract]   [Full Text] [Related]  

  • 54. [Tuberculosis: epidemiologic development and resistance situation].
    Hauer B; Loddenkemper R
    Dtsch Med Wochenschr; 1999 Mar; 124(10):A7-8. PubMed ID: 10191819
    [No Abstract]   [Full Text] [Related]  

  • 55. The incidence of drug resistant tuberculosis in 1279 Korean patients.
    Yum H; Song Y; Jeon S; Choi S; Lee B; Kim D
    Korean J Intern Med; 1995 Jan; 10(1):38-42. PubMed ID: 7626555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tuberculosis in migrants from 106 countries to Italy, 2008-2014.
    Fattorini L; Mustazzolu A; Borroni E; Piccaro G; Giannoni F; Cirillo DM;
    Eur Respir J; 2016 Apr; 47(4):1273-6. PubMed ID: 26846829
    [No Abstract]   [Full Text] [Related]  

  • 57. Tuberculosis in the context of emerging and reemerging diseases.
    Brennan PJ
    FEMS Immunol Med Microbiol; 1997 Aug; 18(4):263-9. PubMed ID: 9348161
    [No Abstract]   [Full Text] [Related]  

  • 58. The World Health Organization and public health research and practice in tuberculosis in India.
    Banerji D
    Int J Health Serv; 2012; 42(2):341-57. PubMed ID: 22611658
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of multidrug-resistant tuberculosis in the 21st century.
    Kaul G; Kapoor E; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Mar; 55(3):215-224. PubMed ID: 30938375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.